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ABSTRACT
This study describes difficulties in the monitoring of a child born during an oral outbreak 
of Chagas disease, in which there are several indications that the transmission occurred 
through the congenital route: 1. the mother was in the third trimester of pregnancy when she 
was infected; 2. She presented high parasitemia at the time of delivery; 3. In both, the mother 
and her daughter, T. cruzi was classified as DTU TcIV. The parasites were not found in the 
blood at birth and the infection was detected only three months later in an asymptomatic 
infant. As the mother and her child live in a highly endemic area, vector transmission could 
not be excluded during this period.
KEYWORDS: Acute Chagas disease. Child. Diagnosis. Trypanosoma cruzi. DTUs. Vertical 
transmission. Oral outbreak. 
INTRODUCTION
Acute Chagas Disease (ACD) was reported in the Amazon Basin, where different 
Trypanosoma cruzi strains circulate in the transmission cycles of mammals and 
triatomine bugs. The population in this area is vulnerable, as it is in close contact 
with domestic and wild mammals, and triatomine vectors. Currently in Brazil, the 
majority of ACD cases are caused by intrafamily outbreaks transmitted orally after 
consumption of artisan foods and beverages, such as acai and the bacaba palm fruit1.
In the Northern region of Brazil, T. cruzi detection is made by direct examination 
of the stained thick-drop slides or blood smears. Serological methods for IgM 
detection were associated with clinical manifestations and epidemiological suspicion 
of ACD. The Polymerase Chain Reaction (PCR) presents promising results, but 
is routinely performed only in reference laboratories and is not available in areas 
where CD transmission is more frequent2. 
In addition to these difficulties with diagnoses, T. cruzi parasites have many 
species and are highly polymorphic, presenting genotypic and phenotypic 
differences, being classified in six Discrete Typing Units (DTU), TcI–TcVI, and 
TcBat3. Previous reports suggest that genotypic and phenotypic differences, in 
addition to the geographical distribution of T. cruzi strains, can be associated with 
the variation in sensitivity of parasitological and serological tests3-5. The genetic 
diversity of T. cruzi has been reported as a possible predisposing factor for vertical 
transmission, due to distinct parasitemia levels; however, all Tc DTUs, with the 
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exception of DTU TcIV, have been reported in congenital 
infections6.
This report describes a T. cruzi infection by DTU TcIV 
in a young pregnant woman and her newborn child, in 
whom vertical transmission could not be proven, but was 
suspected. 
CASE REPORT
This study was approved by the Ethical Committee 
of the Faculdade de Medicina of the Universidade de Sao 
Paulo (approval Nº 2695.519). Written informed consent 
was obtained from adult patients and from parents/guardians 
on behalf of all the participant children. 
An 18-year-old-pregnant woman from the Riverside 
Community of Marimarituba, municipality of Santarem 
(Para State), Brazil, was admitted to Santarem Municipal 
Hospital in April 2016 reporting one week of daily fever, 
myalgia, and two days of diarrhea with peripheral edema. 
T. cruzi trypomastigotes were found in a blood smear; she 
was likely infected twenty-three days before hospitalization, 
when she consumed “bacaba palm fruit wine”. The mother’s 
blood exams revealed lymphopenia and plaquetopenia, while 
the biochemical exams, chest X-ray, and electrocardiogram 
were normal. The serological tests showed showed a 
positive indirect immunofluorescence (IF) test with titers 
of anti-T. cruzi IgG and IgM antibodies of 1/320 and 
1/160, respectively, a positive indirect hemagglutination 
test (IHAT) and a non-reagent ELISA. Quantitative PCR 
(qPCR) for T. cruzi detection was performed with Tcz 3/4 
primers, using a previously described methodology7. A 
burden of 53.51 parasites Eq/mL of blood was found. 
After a spontaneous labor, a vaginal delivery occurred 
six days after the mother arrived at the hospital, at 34 weeks 
and 3 days of gestational age, according to the USG exam. 
The newborn weighed 2.570 kg, had an Apgar score of 
9 and 8 in the 1st and 5th min of life, respectively and the 
physical examination was normal, with no parasitemia 
observed by direct microscopy of peripheral blood. The 
female child remained asymptomatic and three months 
later, a new blood smear was positive by direct microscopy, 
in association with a qPCR detection of 78.3 parasites in 
Eq/mL of blood. The infant was hospitalized, and her total 
blood count showed lymphocytosis; biochemistry, chest 
X-ray, electrocardiogram and echocardiogram were all 
normal. The infant was exclusively breastfed during these 
three months and she was treated with benznidazole for 
60  days (5 mg/kg/day). After 6 months of treatment, a 
new serology was performed with negative ELISA IgG 
and IHAT results.
The mother’s treatment with benznidazole (5 mg/kg/day 
for 60 days) was initiated soon after delivery, and continued 
during the lactation period. The mother’s serology was 
repeated 8 months after the end of treatment and ELISA 
IgG and IHAT remained negative.
T. cruzi was genotyped by two parasite genomic 
sequences: the D7 divergent domain of the 24Sα rRNA 
(24Sα rRNA) and a spliced leader intergenic region 
(SL-IR). To this end, nested and multiplex PCR were 
performed as previously described7. The reference strains 
used in this study are described in Table 1. In the mother 
and the child, amplicons of 120 pb and 150 pb (Figure 1) 
were observed in 24Sα rRNA (Figure 1A) and SL-IR 
(Figure 1B) PCR assays, respectively, corresponding to 
DTU TcIV.
DISCUSSION 
This report describes a T. cruzi infection by DTU 
TcIV in a young pregnant woman with suspected vertical 
transmission of Chagas disease to her child. Congenital 
transmission could not be definitively proven, although 
there were several indications that the transmission took 
place via the congenital route:
Table 1 - Description of Trypanosoma cruzi and Trypanosoma rangeli reference strains used in this study: gene sequences GenBank 





Sequence base pairs 
24Sα rRNA SL- IR
T. cruzi JRcl4 Tc I HQ604893.1 110 200
Y Tc II AF301912 125 250
MT3663 Tc III AF303060 110 150
JJ Tc IV AY491761 120 or 130 150
Bertha Tc V FJ555614 110 and 125 250
CL Brenner Tc VI AF245383 125 250
Tc Bat KT327329 250
T. rangeli Tra 1719 JF421351 100
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-  The mother was in the third trimester when she was 
infected, and she presented with a high parasite load 
at delivery. Some reports demonstrated an increase 
in maternal parasitemia during the third trimester of 
pregnancy with levels over 25.8 parasites in Eq/mL, 
increasing the risk of vertical transmission8,9.
-  Breastfeeding transmission, although possible, has 
not been proven so far. Data on T. cruzi transmission 
through breastfeeding are scarce, and are mainly from 
animal studies. In one rare human study, 100 samples 
of breast milk from 78 women with CD did not detect 
any transmission in a total of 97 infants10.
-  Both in mother and the child, DTU TcIV was identified. 
Despite this finding, it was not possible to prove the 
vertical transmission, so the child returned with her 
mother to the endemic area where they live; yet, we still 
cannot exclude a vector transmission. In the Amazon 
basin, DTU TcIV is detected among non-human 
primates, in vectors, and is also associated with human 
infections11,12.
The congenital transmission, though probable, was 
not confirmed. Indeed, parasites were not found in the 
infant’s blood at birth, and infection was detected only three 
months later in an asymptomatic infant. Despite being a 
preterm newborn (congenital T. cruzi infection can result 
in premature birth), the newborn appeared healthy at birth, 
with no signs of infection. As with most infected children, 
60 to 90% are asymptomatic, with mothers not seeing the 
need for a medical intervention13. The lack of access to 
health professionals in the region (with expansive size and 
hydrography), along with economic issues to get access 
to health centers, tend to create difficulties in an adequate 
follow-up of newborns.
The failure to detect parasites in T. cruzi-infected 
newborns in the first month of life could be attributed to the 
low sensitivity of the assay. Some reports demonstrated a 
68.9% sensitivity in detecting T. cruzi in 267 children up to 
five months of age, with a 44% positivity in the first month. 
Children born to mothers with ACD must be followed for 
12 months14.
Based on reports fromclinical trials conducted in non-
endemic areas of Spain, PCR proved to be a useful tool in 
detecting T. cruzi in the first month of life, and in children born 
to mothers with Chagas disease15. In endemic areas, where 
transmission still occurs with different DTUs of T. cruzi, 
no molecular methods of diagnosis are routinely available. 
Despite the need, PCR is restricted to research centers.
The global rate of vertical transmission observed in 
the American Continent is 2%. Argentina and Bolivia 
concentrate most of the analyzed studies s and are the South 
American countries present the highest transmission rates, 
of 7% and 5%, respectively16. 
Carlier et al.17 reported that mother-to-child transmission 
of CD can occur in infected women living in Latin 
America (LA) or outside LA if they have previously lived 
in an endemic area of LA and/or were born in LA. In 
non-endemic areas, the global rate of Chagas disease is 
3.8% among pregnant women, and the rate of congenital 
transmission is 2.8%. Most of the data available are from 
Spain, the second country in the world with the largest 
number of immigrants from Latin America18.
In Brazil, in a systematic review with data from 
1984-2009 collected in the South, Southeast and Midwest 
regions, indicated a pooled congenital transmission rate of 
1.7%. The estimated rate decreased over time from 2.3% 
between 1990 to 1999 to 0.2% after 200019. However, it is 
important to note that the studies focused on some regions: 
Midwest, South and Southeast. There are no reports on the 
vertical transmission of Chagas disease in the Northern 
region, but this is the region with the highest number of 
notifications of acute cases of Chagas disease in the country, 
2,889 cases between 2013 and 2019 or approximately 222 
cases per year20. 
Limitations of diagnostic tests and the absence of 
symptoms (or the presence of non-specific symptoms) tend 
Figure 1 - Genotyping patterns of T. cruzi sequences 
24Sα rRNA (A) and SL-IR (B). Reference strains: TcI – JR cl4; 
TcII – Y; TcIII – MT366; TcIV – JJ; TcV – Bertha; TcVI – CL 
Brener; Tc bat – 1994; Tr (T. rangeli) – Tra 1719. MM: Molecular 
Marker 100pb; C-: Negative control; Mother (M) and Child (C).
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to lead to the underreporting of DCA and of congenital 
transmissions and the treatment effectiveness and DCA 
prognosis depend on the early and accurate diagnosis of 
the infections. 
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